Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten
Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten is a medicine authorised by Swissmedic under authorisation number 68440. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 April 2022 and the authorisation is valid without a time limit. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 68440 |
|---|---|
| Name | Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten |
| Full name | Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 06 April 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten | B | 06 April 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 56 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 5 | 196 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 6 | 100 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten authorised in Switzerland?
Yes. Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten is authorised by Swissmedic under authorisation number 68440, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten have?
Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban-Mepha Teva vascular 2.5 mg Filmtabletten?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.